"I don't think there are any of us who wouldn't have loved to have Lipitor."

R. Christopher Seaton, senior vice president of global transactions, Bayer Healthcare, commenting on the positive side of Pfizer Inc.'s upcoming patent cliff

"In medicine, you're going to need real improvement to justify the price."

Steve Worland, CEO of Anadys Pharmaceuticals Inc.

"You do have to be somewhat of a Talmudic scholar to prescribe this drug."

Lawrence Friedman, member of the FDA Antiviral Drugs Advisory Committee, referring to the regimen for Merck & Co. Inc.'s hepatitis C candidate boceprevir